We are live on ! Find out more
RGEN icon

Repligen

180 hedge funds and large institutions have $1.14B invested in Repligen in 2017 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 64 increasing their positions, 67 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

19% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 16

15% more capital invested

Capital invested by funds: $995M → $1.14B (+$150M)

0.73% more ownership

Funds ownership: 95.37%96.1% (+0.73%)

4% less repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 67

2% less funds holding

Funds holding: 184180 (-4)

61% less call options, than puts

Call options by funds: $2.06M | Put options by funds: $5.26M

Holders
180
Holders Change
-4
Holders Change %
-2.17%
% of All Funds
4.46%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
19
Increased
64
Reduced
67
Closed
16
Calls
$2.06M
Puts
$5.26M
Net Calls
-$3.2M
Net Calls Change
-$8.24M

RGEN Hedge Fund Activity: Q1 2017 in Review

180 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in Repligen (RGEN) for Q1 2017, worth a combined $1.14B — up 15% from $995M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new RGEN positions and 16 closed out — a net gain of 3 holders — while 64 added to existing stakes and 67 trimmed.

The largest buyer was BlackRock, adding an estimated $148M. The largest seller was Marshall Wace, exiting entirely with an estimated $10.5M sold.

  • 180 institutional investors held Repligen (RGEN) as of Q1 2017, down from 184 in Q4 2016.
  • Funds reported $1.14B of Repligen stock for Q1 2017, up 15% quarter-over-quarter.
  • 19 funds opened new Repligen positions in Q1 2017 and 16 closed out, a net change of +3 holders.
  • The largest Repligen buyer in Q1 2017 was BlackRock, an estimated $148M added.
  • The largest Repligen seller in Q1 2017 was Marshall Wace, an estimated $10.5M sold.

Based on aggregated 13F filings for Q1 2017.